Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.59 |
| ▸ | RAB9A | P51151 | 3/20 | 0.59 |
| ▸ | NPC1 | O15118 | 2/20 | 0.59 |
| ▸ | MAPT | P10636 | 1/20 | 0.59 |
| ▸ | ESR1 | P03372 | 3/20 | 0.57 |
| ▸ | TSHR | P16473 | 3/20 | 0.57 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.57 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.57 |
| ▸ | KDR | P35968 | 1/20 | 0.57 |
| ▸ | CA12 | O43570 | 1/20 | 0.55 |
| ▸ | CA1 | P00915 | 1/20 | 0.55 |
| ▸ | CA2 | P00918 | 1/20 | 0.55 |
| ▸ | CA7 | P43166 | 1/20 | 0.55 |
| ▸ | CA9 | Q16790 | 1/20 | 0.55 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.55 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.55 |
| ▸ | GAA | P10253 | 2/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 5/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29735076 | 0.94 | TDP1 (0.55) | TDP1ALDH1A1RAB9ANPC1MAPT | |
| SCHEMBL14722813 | 0.94 | TDP1 (0.55) | TDP1ALDH1A1RAB9ANPC1MAPT | |
| Ethylene Glycol SCHEMBL3446601 | 0.94 | TDP1 (0.55) | TDP1ALDH1A1RAB9ANPC1MAPT | |
| SCHEMBL29735153 | 0.94 | TDP1 (0.55) | TDP1ALDH1A1RAB9ANPC1MAPT | |
| SCHEMBL756980 | 0.92 | TDP1 (0.59) | TDP1ALDH1A1RAB9ANPC1MAPT | |
| SCHEMBL14722402 | 0.92 | NPC1 (0.72) | TDP1ALDH1A1RAB9ANPC1MAPT | |
| SCHEMBL13410610 | 0.91 | TSHR (0.59) | TDP1ALDH1A1RAB9ANPC1MAPT | |
| SCHEMBL6578044 | 0.91 | TDP1 (0.64) | TDP1ALDH1A1RAB9ANPC1MAPT | |
| SCHEMBL23487801 | 0.90 | ALDH1A1 (0.53) | TDP1ALDH1A1RAB9ANPC1MAPT | |
| SCHEMBL4758615 | 0.90 | TDP1 (0.52) | TDP1ALDH1A1RAB9ANPC1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108473752-B | Resin composition and use thereof | 日本瑞翁株式会社 | 2024-03-22 | — | — | CN | disclosed |
| CN-117445376-A | Method for manufacturing polarizing plate | 日本瑞翁株式会社 | 2024-01-26 | — | — | CN | disclosed |
| WO-2023074843-A1 | NOVEL OLIGOSACCHARIDE, MANUFACTURING INTERMEDIATE FOR NOVEL OLIGOSACCHARIDE, AND METHOD FOR MANUFACTURING THESE | 第一三共株式会社 | 2023-05-04 | — | — | WO | disclosed |
| US-20230028235-A1 | Pre-Processing Method | NIPPON TELEGRAPH AND TELEPHONE CORPORATION (JP) | 2023-01-26 | — | — | US | disclosed |
| US-20220387402-A1 | COMBINATIONS COMPRISING BENZODIOXOL AS GLP-1R AGONISTS FOR USE IN THE TREATMENT OF NASH/NAFLD AND RELATED DISEASES | PFIZER INC. (US) | 2022-12-08 | — | — | US | disclosed |
| EP-3114112-B1 | CRYSTALLINE DERIVATIVES OF (S)-1-((2R,3R,4S,5S)-5-ALLYL-3-METHOXY-4-(TOSYLMETHYL)TETRAHYDROFURAN-2-YL)-3-AMINOPROPAN-2-OL | ALPHORA RES INC (CA) | 2021-12-15 | — | — | EP | disclosed |
| US-10865302-B2 | Resin composition and use thereof | ZEON CORPORATION (JP) | 2020-12-15 | — | — | US | disclosed |
| US-20190040249-A1 | RESIN COMPOSITION AND USE THEREOF | ZEON CORPORATION (JP) | 2019-02-07 | — | — | US | disclosed |
| US-9250359-B2 | Hard coat film, polarizing plate, method for producing hard coat film, and method for producing liquid crystal panel | KONICA MINOLTA OPTO, INC. (JP) | 2016-02-02 | — | — | US | disclosed |
| US-9081133-B2 | Polarizing plate protective film, polarizing plate, and liquid crystal display | Konica Minolta, Inc. (JP) | 2015-07-14 | — | — | US | disclosed |
| US-20080057227-A1 | Manufacturing method of cellulose acylate film, cellulose acylate film, polarizing plate and liquid crystal display | KONICA MINOLTA OPTO, INC. (JP) | 2008-03-06 | — | — | US | disclosed |
| US-20070222920-A1 | POLARIZER PROTECTIVE FILM, POLARIZING PLATE AND VA MODE LIQUID CRYSTAL DISPLAY | KONICA MINOLTA OPTO, INC. (JP) | 2007-09-27 | — | — | US | disclosed |
| US-20070218218-A1 | Cellulose acylate optical film, producing method thereof, polarizing plate and liquid crystal display using the same | KONICA MINOLTA OPTO, INC. (JP) | 2007-09-20 | — | — | US | disclosed |
| US-20070128380-A1 | Cellulose Ester Film, Its Manufacturing Method, Polarizing Plate, and Liquid Crystal Display | KONICA MINOLTA OPTO, INC. (JP) | 2007-06-07 | — | — | US | disclosed |
| US-20070092663-A1 | Cellulose ester film, polarizing plate and display | KONICA MINOLTA OPTO, INC. | 2007-04-26 | — | — | US | disclosed |
| US-20070046870-A1 | Liquid crystal display device | KONICA MINOLTA OPTO, INC. | 2007-03-01 | — | — | US | disclosed |
| US-20060292315-A1 | Polarizing plate and display device | KONICA MINOLTA OPTO, INC (JP) | 2006-12-28 | — | — | US | disclosed |
| US-20060233973-A1 | Cellulose ester film, manufacturing method thereof, optical film, polarizing plate and liquid crystal display | KONICA MINOLTA OPTO, INC. | 2006-10-19 | — | — | US | disclosed |
| US-20060216437-A1 | Optical compensation film, method for producing optical compensation film, polarization plate and liquid crystal display | KONICA MINOLTA OPTO, INC. (JP) | 2006-09-28 | — | — | US | disclosed |
| US-20060069192-A1 | Method for manufacturing cellulose ester film, and cellulose ester film, optical film, polarizing plate and liquid crystal display device using the same | KONICA MINOLTA OPTO, INC. (JP) | 2006-03-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220387402-A1 | COMBINATIONS COMPRISING BENZODIOXOL AS GLP-1R AGONISTS FOR USE IN THE TREATMENT OF NASH/NAFLD AND RELATED DISEASES | GLP1R, GCKR, GCGR | TDP1 4476/4885ALDH1A1 1061/4885RAB9A 3847/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.